VIDT / USDT

PDA / USDT

VIDT / BTC

AUCTION / BTC

BANANA / BTC

BANANA / TRY

BANANA / USDT

AUCTION / FDUSD

VANA / USDT

VANA / FDUSD

WIN / BNB

TST / FDUSD

TST / TRY

TST / USDT

SOLV / BNB

SOLV / FDUSD

SOLV / TRY

SOLV / USDT

EPIC / USDT

COMBO / TRY

WOL 3D INDIA LIMITED

VIBHOR STEEL TUBES LTD

MANUGRAPH INDIA LIMITED

SANGINITA CHEMICALS LTD

RAJESH EXPORTS LTD

EURO PANEL PRODUCTS LTD

SML ISUZU LIMITED

SPECIALITY REST LTD

LIKHITHA INFRASTRUC LTD

STEEL EXCHANGE INDIA LTD

KEI INDUSTRIES LTD.

ROCKINGDEALS CIRCU ECO L

NEELAM LINENS & GAR (I) L

P S RAJ STEELS LIMITED

PRAXIS HOME RETAIL LTD

PRAMARA PROMOTIONS LTD

ADROIT INFOTECH LIMITED

KHANDWALA SECURITIES LTD

PREMIUM PLAST LIMITED

SHREE TIRUPATI BALAJEE L

Click here to get full coverage on Alkem Laboratories eyes bigger pie of diabetes, weightloss market - Business Standard

Alkem Laboratories eyes bigger pie of diabetes, weightloss market  Business Standard

Alkem Laboratories eyes bigger pie of diabetes, weightloss market - Business Standard

Click here to get full coverage on Alkem Laboratories Launches Affordable Generic Empagliflozin In India Under The Brand “Empanorm” - BW Healthcare World

Alkem Laboratories Launches Affordable Generic Empagliflozin In India Under The Brand “Empanorm”  BW Healthcare World

Alkem Laboratories Launches Affordable Generic Empagliflozin In India Under The Brand “Empanorm” - BW Healthcare World

Click here to get full coverage on India's Alkem Labs denies its products failed quality test - Reuters.com

India's Alkem Labs denies its products failed quality test  Reuters.com

India's Alkem Labs denies its products failed quality test - Reuters.com

Click here to get full coverage on Stocks To Buy: Alkem Labs, Pidilite Industries, Anand Rathi, Canara Bank And More - NDTV Profit

Stocks To Buy: Alkem Labs, Pidilite Industries, Anand Rathi, Canara Bank And More  NDTV Profit

Stocks To Buy: Alkem Labs, Pidilite Industries, Anand Rathi, Canara Bank And More - NDTV Profit

Click here to get full coverage on Alkem MedTech enters into a landmark agreement with Exactech for manufacturing and marketing knee and hip replacement implants in India - PR Newswire

Alkem MedTech enters into a landmark agreement with Exactech for manufacturing and marketing knee and hip replacement implants in India  PR Newswire

Alkem MedTech enters into a landmark agreement with Exactech for manufacturing and marketing knee and hip replacement implants in India - PR Newswire

Click here to get full coverage on Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India - GlobeNewswire

Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India  GlobeNewswire

Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India - GlobeNewswire

Click here to get full coverage on Alkem Labs duped of ₹22 cr by frauds pretending to be officials of its US arm - Hindustan Times

Alkem Labs duped of ₹22 cr by frauds pretending to be officials of its US arm  Hindustan Times

Alkem Labs duped of ₹22 cr by frauds pretending to be officials of its US arm - Hindustan Times

Click here to get full coverage on Alkem Laboratories makes twin acquisitions - Mint

Alkem Laboratories makes twin acquisitions  Mint

Alkem Laboratories makes twin acquisitions - Mint

Click here to get full coverage on Alkem Laboratories Ltd (ALKEM) Share Price - Business Today

Alkem Laboratories Ltd (ALKEM) Share Price  Business Today

Alkem Laboratories Ltd (ALKEM) Share Price - Business Today

Click here to get full coverage on Stocks to Watch Today: IndusInd Bank, Brigade, Maharashtra Seamless, GR Infraprojects, Shilpa Medicare,... - Moneycontrol

Stocks to Watch Today: IndusInd Bank, Brigade, Maharashtra Seamless, GR Infraprojects, Shilpa Medicare,...  Moneycontrol

Stocks to Watch Today: IndusInd Bank, Brigade, Maharashtra Seamless, GR Infraprojects, Shilpa Medicare,... - Moneycontrol

Click here to get full coverage on Alkem launches generic empagliflozin low-cost diabetes drug in India - BusinessLine

Alkem launches generic empagliflozin low-cost diabetes drug in India  BusinessLine

Alkem launches generic empagliflozin low-cost diabetes drug in India - BusinessLine

Click here to get full coverage on Alkem Laboratories' Bioequivalence Center clears US FDA inspection without observations - CNBCTV18

Alkem Laboratories' Bioequivalence Center clears US FDA inspection without observations  CNBCTV18

Alkem Laboratories' Bioequivalence Center clears US FDA inspection without observations - CNBCTV18

Click here to get full coverage on Alkem Labs acquires two companies specialising in skin care, medtech to bolster domestic business - The Economic Times

Alkem Labs acquires two companies specialising in skin care, medtech to bolster domestic business  The Economic Times

Alkem Labs acquires two companies specialising in skin care, medtech to bolster domestic business - The Economic Times

Click here to get full coverage on Pfizer Sues Alkem to Block Copies of Blockbuster Xeljanz Drug - Bloomberg Law

Pfizer Sues Alkem to Block Copies of Blockbuster Xeljanz Drug  Bloomberg Law

Pfizer Sues Alkem to Block Copies of Blockbuster Xeljanz Drug - Bloomberg Law

Click here to get full coverage on Alkem Laboratories Shows Trend Reversal Amid Broader Market Gains and Mixed Signals - MarketsMojo

Alkem Laboratories Shows Trend Reversal Amid Broader Market Gains and Mixed Signals  MarketsMojo

Alkem Laboratories Shows Trend Reversal Amid Broader Market Gains and Mixed Signals - MarketsMojo

Click here to get full coverage on Alkem Lab gains as Bioequivalence Center clears USFDA inspection without observations - Business Standard

Alkem Lab gains as Bioequivalence Center clears USFDA inspection without observations  Business Standard

Alkem Lab gains as Bioequivalence Center clears USFDA inspection without observations - Business Standard

Click here to get full coverage on Alkem Labs announces acquisitions in skincare and medical devices segments - BusinessLine

Alkem Labs announces acquisitions in skincare and medical devices segments  BusinessLine

Alkem Labs announces acquisitions in skincare and medical devices segments - BusinessLine

Click here to get full coverage on Alkem Laboratories Shows Trend Reversal Amid Broader Market Recovery Dynamics - MarketsMojo

Alkem Laboratories Shows Trend Reversal Amid Broader Market Recovery Dynamics  MarketsMojo

Alkem Laboratories Shows Trend Reversal Amid Broader Market Recovery Dynamics - MarketsMojo

Click here to get full coverage on Alkem Laboratories launches generic Empagliflozin in India - Business Standard

Alkem Laboratories launches generic Empagliflozin in India  Business Standard

Alkem Laboratories launches generic Empagliflozin in India - Business Standard

Click here to get full coverage on Alkem Lab's Bioequivalence Center clears USFDA inspection without observations - Business Standard

Alkem Lab's Bioequivalence Center clears USFDA inspection without observations  Business Standard

Alkem Lab's Bioequivalence Center clears USFDA inspection without observations - Business Standard

Click here to get full coverage on Alkem to buy two firms - The Times of India

Alkem to buy two firms  The Times of India

Alkem to buy two firms - The Times of India

Click here to get full coverage on Alkem Labs Q3 Results: Net profit rises just 6% to ₹641 crore, total income flat; stock declines 4% - Mint

Alkem Labs Q3 Results: Net profit rises just 6% to ₹641 crore, total income flat; stock declines 4%  Mint

Alkem Labs Q3 Results: Net profit rises just 6% to ₹641 crore, total income flat; stock declines 4% - Mint

Click here to get full coverage on Alkem Laboratories launches generic empagliflozin in India - Business Standard

Alkem Laboratories launches generic empagliflozin in India  Business Standard

Alkem Laboratories launches generic empagliflozin in India - Business Standard

Click here to get full coverage on Alkem Labs diversifies into medical devices biz - The Economic Times

Alkem Labs diversifies into medical devices biz  The Economic Times

Alkem Labs diversifies into medical devices biz - The Economic Times

Click here to get full coverage on Alkem joins $3 bn race for JB Chem as Torrent pauses talks - The Economic Times

Alkem joins $3 bn race for JB Chem as Torrent pauses talks  The Economic Times

Alkem joins $3 bn race for JB Chem as Torrent pauses talks - The Economic Times

Click here to get full coverage on Alkem Laboratories announces appointment of senior management personnel - Business Standard

Alkem Laboratories announces appointment of senior management personnel  Business Standard

Alkem Laboratories announces appointment of senior management personnel - Business Standard

Click here to get full coverage on Alkem Launches Generic Diabetes Drug Empanorm in India - Rediffmail

Alkem Launches Generic Diabetes Drug Empanorm in India  Rediffmail

Alkem Launches Generic Diabetes Drug Empanorm in India - Rediffmail

Click here to get full coverage on Alkem, Sonnet ink pact for diabetic neuropathy - The Economic Times

Alkem, Sonnet ink pact for diabetic neuropathy  The Economic Times

Alkem, Sonnet ink pact for diabetic neuropathy - The Economic Times

Click here to get full coverage on Alkem arm ties up with Exactech for knee, hip replacement implants - The Economic Times

Alkem arm ties up with Exactech for knee, hip replacement implants  The Economic Times

Alkem arm ties up with Exactech for knee, hip replacement implants - The Economic Times

Click here to get full coverage on Exactech partners with Alkem MedTech for joint implants in India - Medical Device Network

Exactech partners with Alkem MedTech for joint implants in India  Medical Device Network

Exactech partners with Alkem MedTech for joint implants in India - Medical Device Network

Click here to get full coverage on Alkem inks licensing pact with Takeda to introduce Vonoprazan in India - The Economic Times

Alkem inks licensing pact with Takeda to introduce Vonoprazan in India  The Economic Times

Alkem inks licensing pact with Takeda to introduce Vonoprazan in India - The Economic Times

Click here to get full coverage on Alkem Labs looks to acquire JB Pharma as Torrent pulls out of talks: Report - Moneycontrol

Alkem Labs looks to acquire JB Pharma as Torrent pulls out of talks: Report  Moneycontrol

Alkem Labs looks to acquire JB Pharma as Torrent pulls out of talks: Report - Moneycontrol

Click here to get full coverage on Alkem Labs Q2 Results: Revenue falls but profit and margin expand from last year - CNBCTV18

Alkem Labs Q2 Results: Revenue falls but profit and margin expand from last year  CNBCTV18

Alkem Labs Q2 Results: Revenue falls but profit and margin expand from last year - CNBCTV18

Click here to get full coverage on Alkem promoters may sell stake; tap PE firms KKR, Blackstone, EQT - Moneycontrol

Alkem promoters may sell stake; tap PE firms KKR, Blackstone, EQT  Moneycontrol

Alkem promoters may sell stake; tap PE firms KKR, Blackstone, EQT - Moneycontrol

Click here to get full coverage on Alkem Labs sees Rs 300 crore worth equity change hands in large deal - Moneycontrol

Alkem Labs sees Rs 300 crore worth equity change hands in large deal  Moneycontrol

Alkem Labs sees Rs 300 crore worth equity change hands in large deal - Moneycontrol

Click here to get full coverage on USFDA inspection: Alkem Labs concludes inspection at Taloja Center - Medical Dialogues

USFDA inspection: Alkem Labs concludes inspection at Taloja Center  Medical Dialogues

USFDA inspection: Alkem Labs concludes inspection at Taloja Center - Medical Dialogues

Click here to get full coverage on Alkem Labs' Taloja Bioequivalence Center Clears USFDA Inspection - Indiainfoline

Alkem Labs' Taloja Bioequivalence Center Clears USFDA Inspection  Indiainfoline

Alkem Labs' Taloja Bioequivalence Center Clears USFDA Inspection - Indiainfoline

Click here to get full coverage on Alkem Reports Strong Q3FY25 Earnings - BW Healthcare World

Alkem Reports Strong Q3FY25 Earnings  BW Healthcare World

Alkem Reports Strong Q3FY25 Earnings - BW Healthcare World

Click here to get full coverage on Alkem Labs announces strategic acquisitions in skincare and medical devices sector - BSI bureau

Alkem Labs announces strategic acquisitions in skincare and medical devices sector  BSI bureau

Alkem Labs announces strategic acquisitions in skincare and medical devices sector - BSI bureau

Click here to get full coverage on Alkem Labs Acquires Adroit Biomed & Bombay Ortho - Healthcare Radius

Alkem Labs Acquires Adroit Biomed & Bombay Ortho  Healthcare Radius

Alkem Labs Acquires Adroit Biomed & Bombay Ortho - Healthcare Radius

Click here to get full coverage on Alkem Labs Q2 Results: Net profit rises 11% to Rs 689 crore - The Economic Times

Alkem Labs Q2 Results: Net profit rises 11% to Rs 689 crore  The Economic Times

Alkem Labs Q2 Results: Net profit rises 11% to Rs 689 crore - The Economic Times

Click here to get full coverage on Popular anti-diabetes drug now sold at one-tenth of its cost - India Today

Popular anti-diabetes drug now sold at one-tenth of its cost  India Today

Popular anti-diabetes drug now sold at one-tenth of its cost - India Today

Click here to get full coverage on After Torrent Pharma, Alkem Labs Denies Claims on Drug Failing Quality Test - NDTV Profit

After Torrent Pharma, Alkem Labs Denies Claims on Drug Failing Quality Test  NDTV Profit

After Torrent Pharma, Alkem Labs Denies Claims on Drug Failing Quality Test - NDTV Profit

Click here to get full coverage on Stocks To Buy Today: ITC, Devyani International, Sun Pharma, Alkem Labs And More - NDTV Profit

Stocks To Buy Today: ITC, Devyani International, Sun Pharma, Alkem Labs And More  NDTV Profit

Stocks To Buy Today: ITC, Devyani International, Sun Pharma, Alkem Labs And More - NDTV Profit

Click here to get full coverage on Alkem Labs: Equity worth Rs 487 crore changes hands as promoter likely offloads stake - Moneycontrol

Alkem Labs: Equity worth Rs 487 crore changes hands as promoter likely offloads stake  Moneycontrol

Alkem Labs: Equity worth Rs 487 crore changes hands as promoter likely offloads stake - Moneycontrol

Click here to get full coverage on Alkem Laboratories promoter's wife purchases luxury apartment for ₹185 crore in Mumbai's Worli - Hindustan Times

Alkem Laboratories promoter's wife purchases luxury apartment for ₹185 crore in Mumbai's Worli  Hindustan Times

Alkem Laboratories promoter's wife purchases luxury apartment for ₹185 crore in Mumbai's Worli - Hindustan Times

Click here to get full coverage on Novartis India refutes media reports of negotiations with Alkem Labs - domain-b.com: The first online Indian business magazine

Novartis India refutes media reports of negotiations with Alkem Labs  domain-b.com: The first online Indian business magazine

Novartis India refutes media reports of negotiations with Alkem Labs - domain-b.com: The first online Indian business magazine

Click here to get full coverage on Rs 22 Crore Gone in a Click: Pharma Giant Alkem Labs Falls Victim to Cyber Fraud - Medical Dialogues

Rs 22 Crore Gone in a Click: Pharma Giant Alkem Labs Falls Victim to Cyber Fraud  Medical Dialogues

Rs 22 Crore Gone in a Click: Pharma Giant Alkem Labs Falls Victim to Cyber Fraud - Medical Dialogues

Click here to get full coverage on Alkem Labs promoters sell Rs 300-cr shares in block deal - The Economic Times

Alkem Labs promoters sell Rs 300-cr shares in block deal  The Economic Times

Alkem Labs promoters sell Rs 300-cr shares in block deal - The Economic Times

Click here to get full coverage on Alkem Laboratories Faces Sustained Underperformance Amid Broader Pharmaceutical Sector Decline - MarketsMojo

Alkem Laboratories Faces Sustained Underperformance Amid Broader Pharmaceutical Sector Decline  MarketsMojo

Alkem Laboratories Faces Sustained Underperformance Amid Broader Pharmaceutical Sector Decline - MarketsMojo

Click here to get full coverage on ALKEM Outlook for the Week (March 10, 2025 – March 14, 2025) - EquityPandit

ALKEM Outlook for the Week (March 10, 2025 – March 14, 2025)  EquityPandit

ALKEM Outlook for the Week (March 10, 2025 – March 14, 2025) - EquityPandit

Click here to get full coverage on Alkem Laboratories Q3 results: Net profit rises 5.2% to Rs 625 crore - Business Standard

Alkem Laboratories Q3 results: Net profit rises 5.2% to Rs 625 crore  Business Standard

Alkem Laboratories Q3 results: Net profit rises 5.2% to Rs 625 crore - Business Standard

Click here to get full coverage on Alkem Laboratories (NSE:ALKEM) shareholders have earned a 14% CAGR over the last five years - Simply Wall St

Alkem Laboratories (NSE:ALKEM) shareholders have earned a 14% CAGR over the last five years  Simply Wall St

Alkem Laboratories (NSE:ALKEM) shareholders have earned a 14% CAGR over the last five years - Simply Wall St

Click here to get full coverage on Alkem Labs signs licensing agreement with Sonnet BioTherapeutics to develop diabetic neuropathy treatment - CNBCTV18

Alkem Labs signs licensing agreement with Sonnet BioTherapeutics to develop diabetic neuropathy treatment  CNBCTV18

Alkem Laboratories Limited (ALKEM)

Price Chart

Key Statistics

Technicals

About ALKEM

Latest News

Alkem Laboratories eyes bigger pie of diabetes, weightloss market - Business Standard

Alkem Laboratories Launches Affordable Generic Empagliflozin In India Under The Brand “Empanorm” - BW Healthcare World

India's Alkem Labs denies its products failed quality test - Reuters.com

Advanced Charts

Top Gainers

Top Losers